Nisha Bansal

Dr. Nisha Bansal

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2025 in Analytica
Verified
Journal Article
Open access
PDF file
RKRam Kumar
Ram Kumar
SSSushant Salwan
Sushant Salwan
PKPawan Kumar
Pawan Kumar
NBNisha Bansal
Nisha Bansal
Bhupinder KumarBhupinder Kumar
Bhupinder Kumar
Electroanalysis has emerged as a critical tool in the pharmaceutical industry, offering versatile and sensitive methods for drug analysis. This review explores the principles, techniques, and applications of electroanalysis in pharmaceuticals, emphasizing its role in drug development, quality assurance, pharmacokinetics, and environmental monitoring. Key electroanalytical methods, including voltammetry, potentiometry, and amperometry, are detailed along with their practical applications, such as detecting active pharmaceutical ingredients, monitoring drug metabolites, and ensuring product stability. Innovations in electrode materials and biosensors have enhanced their sensitivity and specificity, paving the way for advanced drug screening and therapeutic monitoring. Challenges like electrode fouling, selectivity issues, and regulatory constraints are discussed, along with strategies to overcome them. Future trends highlight the integration of nanotechnology, AI, and portable sensors to facilitate real-time analysis and personalized medicine. These advancements position electroanalysis as an indispensable component of modern pharmaceutical research and healthcare. Future perspectives emphasize the integration of nanotechnology and artificial intelligence (AI) to optimize experimental processes and data interpretation. This study also predicts the increased adoption of lab-on-a-chip systems and bioelectrochemical sensors to meet the growing demand for precision medicine and sustainable pharmaceutical practices. These advancements position electroanalysis as a cornerstone of pharmaceutical research, paving the way for more efficient drug development, improved patient outcomes and better environmental management. This comprehensive review underscores the transformative potential of electroanalysis in addressing the evolving challenges of the pharmaceutical industry and provides a foundation for future innovations. This review does not explicitly define the timeframe for the considered advancements. However, it discusses recent technological developments, including innovations in nanostructured electrodes, microfluidic integration, and AI-driven data analysis, indicating a focus on advancements primarily from the last few years, i.e., from 2020 to 2025.

13 February 2026 in Biophysica
Verified
Journal Article
Open access
PDF file
IPIndu Passi
Indu Passi
NBNisha Bansal
Nisha Bansal
TSThakur Gurjeet Singh
Thakur Gurjeet Singh
Bhupinder KumarBhupinder Kumar
Bhupinder Kumar
Neurodegenerative conditions such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis (ALS) are devastating disorders with the gradual loss of neurons and cognitive or motor disability. This is a review article that develops the crucial functions of autophagy and proteostasis within the scope of the neurodegenerative disease. Autophagy is a very well-conserved cell process that poses a quality control checkpoint that allows for the degradation and recycling of damaged organelles and misfolded proteins. Chaperones, the ubiquitin–proteasome complexes, and endoplasmic reticulum-associated degradation (ERAD) are also referred to as proteostasis, which plays a key role in ensuring the correct protein folding properties and the prevention of toxic protein accumulation. This article offers a detailed discussion of the relationship between autophagy and proteostasis, illustrating the mechanisms of mutual cooperation of these processes, ensuring cellular homeostasis and inhibiting the formation of pathogenic protein aggregates. In addition, this review includes experimental data during preclinical studies and clinical trials and expounds on the therapeutic opportunities that show the potential of targeting autophagy and proteostasis to counter neurodegenerative disorders. Although research progress creates potential for new indicators, the issues and difficulties relating to the effects of regulating such complex cellular pathways are also discussed in the article. Finally, the review can add to the research of neurodegenerative disease mechanisms of autophagy and proteostasis as well as provide insights about the future of treatment and its implementation.

27 November 2025 in Luminescence
Verified
Journal Article
Closed access
ANAravind R Nesaragi
Aravind R Nesaragi
JNJyoti Nagalik
Jyoti Nagalik
SCSharanappa Chapi
Sharanappa Chapi
NBNisha Bansal
Nisha Bansal
TSThakur Gurjeet Singh
Thakur Gurjeet Singh
NANabil Alzaqri
Nabil Alzaqri

20 January 2026 in Archiv der Pharmazie
Verified
Journal Article
Closed access
Nemat AliNemat Ali
Nemat Ali
FAFahad T. Alotaibi
Fahad T. Alotaibi
MBM. Arockia Babu
M. Arockia Babu
TSThakur Gurjeet Singh
Thakur Gurjeet Singh
AAAli M. Alaseem
Ali M. Alaseem
NBNisha Bansal
Nisha Bansal

25 October 2025 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
AAAli M. Alaseem
Ali M. Alaseem
SRSummya Rashid
Summya Rashid
JPJ. Puneetha
J. Puneetha
MBM. Arockia Babu
M. Arockia Babu
GAGlowi Alasiri
Glowi Alasiri
NBNisha Bansal
Nisha Bansal

31 July 2025 in Drug Development Research
Verified
Journal Article
Closed access
AAAli Alaseem
Ali Alaseem
GAGlowi Ali Alasiri
Glowi Ali Alasiri
AMArockia Babu Marianesan
Arockia Babu Marianesan
TSThakur Gurjeet Singh
Thakur Gurjeet Singh
PAPrawez Alam
Prawez Alam
NBNisha Bansal
Nisha Bansal